Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Abdel-Wahab, N."'
Autor:
Reid P; Division of Rheumatology, Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA., Sandigursky S; Division of Rheumatology, Department of Medicine, NYU Langone Health, New York, NY, USA., Song J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lopez-Olivo MA; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Safa H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cytryn S; Division of Internal Medicine, Department of Medicine, NYU Langone Health, New York, TX, USA., Efuni E; Division of Internal Medicine, Department of Medicine, NYU Langone Health, New York, TX, USA., Buni M; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pavlick A; Medical Oncology, Weill Cornell Medical Center, New York, NY, USA., Krogsgaard M; Perlmutter Cancer Center, Department of Pathology, NYU Langone Health, New York, NY, USA., Abu-Shawer O; Department of Internal Medicine, Harvard Medical School, Boston, MA, USA.; Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA., Altan M; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weber JS; Perlmutter Cancer Center, Department of Medicine, NYU Langone Health, New York, NY, USA., Rahma OE; Department of Internal Medicine, Harvard Medical School, Boston, MA, USA.; Department of Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA., Suarez-Almazor ME; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abdel-Wahab N; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Rheumatology and Rehabilitation, Faculty of Medicine, Assiut University Hospitals, Assiut, Egypt.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2023 Oct 30; Vol. 12 (1), pp. 2261264. Date of Electronic Publication: 2023 Oct 30 (Print Publication: 2023).
Autor:
Fa'ak F; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA., Buni M; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Falohun A; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lu H; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Song J; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Johnson DH; Ochsner Health, New Orleans, Louisiana, USA., Zobniw CM; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Trinh VA; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Awiwi MO; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tahon NH; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Elsayes KM; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ludford K; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Montazari EJ; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chernis J; University of Texas Health Science Center at Houston John P and Katherine G McGovern Medical School, Houston, Texas, USA., Dimitrova M; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA., Sandigursky S; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA., Sparks JA; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Abu-Shawer O; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Rahma O; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Thanarajasingam U; Mayo Clinic, Rochester, Minnesota, USA., Zeman AM; Mayo Clinic, Rochester, Minnesota, USA., Talukder R; Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle, Washington, USA., Singh N; Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle, Washington, USA., Chung SH; Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle, Washington, USA., Grivas P; Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle, Washington, USA., Daher M; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Abudayyeh A; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Osman I; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA., Weber J; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA., Tayar JH; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Suarez-Almazor ME; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Abdel-Wahab N; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Assiut University Faculty of Medicine, Assiut University Hospitals, Assiut, Egypt., Diab A; University of Texas MD Anderson Cancer Center, Houston, Texas, USA adiab@mdanderson.org.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jun; Vol. 11 (6).
Autor:
Abdel-Wahab N; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Rheumatology and Rehabilitation, Faculty of Medicine, Assiut University Hospitals, Assiut, Egypt.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yu RK; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Criswell LA; Russell/Engleman Rheumatology Research Center, Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Tayar JH; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dadu R; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shannon V; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shete SS; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sshete@mdanderson.org.; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sshete@mdanderson.org., Suarez-Almazor ME; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. msalmazor@mdanderson.org.; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. msalmazor@mdanderson.org.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Jul; Vol. 70 (7), pp. 1939-1949. Date of Electronic Publication: 2021 Jan 07.
Autor:
Abdelrahim M; Institute of Academic Medicine and Weill Cornell Medical College, Houston Methodist Cancer Center, Houston, Texas, USA., Mamlouk O; Section of Nephrology, Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lin H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lin J; Section of Nephrology, Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Page V; Section of Nephrology, Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Abdel-Wahab N; Rheumatology and Rehabilitation Department, Assiut University Hospitals, Faculty of Medicine, Assiut, Egypt.; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Swan J; Department of System Pharmacy, Houston Methodist, Houston, Texas, USA., Selamet U; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Yee C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Suki W; Department of Medicine, Nephrology, Houston Methodist Hospital, Houston, Texas, USA., Abudayyeh A; Section of Nephrology, Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2021 May 23; Vol. 10 (1), pp. 1927313. Date of Electronic Publication: 2021 May 23.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Abdel-Wahab, N.1 (AUTHOR), Montazari, E.J.2 (AUTHOR), Spillson, C.2 (AUTHOR), Amaria, R.2 (AUTHOR), Glitza, I.C.2 (AUTHOR), Patel, S.2 (AUTHOR), Awiwi, M.3 (AUTHOR), Hassan, A.3 (AUTHOR), Tahon, N.3 (AUTHOR), Elsayes, K.M.3 (AUTHOR), Altan, M.4 (AUTHOR), Wong, M.2 (AUTHOR), Mcquade, J.2 (AUTHOR), Tawbi, H.A.2 (AUTHOR), Davies, M.2 (AUTHOR), Yee, C.2 (AUTHOR), Sharma, P.5 (AUTHOR), Allison, J.6 (AUTHOR), Johnson, D.7 (AUTHOR), Diab, A.2 (AUTHOR)
Publikováno v:
Annals of Oncology. 2022 Supplement 7, Vol. 33, pS923-S923. 1p.
Autor:
Diab, A.1 (AUTHOR), Abdel-Wahab, N.2 (AUTHOR), Bentebibel, S.E.1 (AUTHOR), Montazari, E.J.1 (AUTHOR), Spillson, C.A.1 (AUTHOR), Ekmekcioglu, S.1 (AUTHOR), Gao, J.3 (AUTHOR), Altan, M.4 (AUTHOR)
Publikováno v:
Annals of Oncology. 2021 Supplement 7, Vol. 32, pS1456-S1456. 1p.